Status:
COMPLETED
Impact of Direct Outreach to Expand Access to Naloxone in the Context of Standing Orders
Lead Sponsor:
Kaiser Permanente
Collaborating Sponsors:
Denver Health and Hospital Authority
National Institute on Drug Abuse (NIDA)
Conditions:
Opioid Abuse
Overdose
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
In the setting of naloxone standing orders, this study will assess if direct outreach with a web-based "Naloxone Navigator 1.0" to patients prescribed chronic opioid therapy (COT) changes opioid risk ...
Detailed Description
This is a randomized study of a web-based naloxone educational resource (Naloxone Navigator 1.0) for adults prescribed chronic opioid therapy. This study will be conducted under new naloxone standing ...
Eligibility Criteria
Inclusion
- 18 years of age or greater prescribed chronic opioid therapy
Exclusion
- Non-English speaking, hospice enrollment, do-not-resuscitate order, receipt of naloxone in the last 12 months, no internet access, not planning to continue to receive care in the same setting for the next 4 months.
Key Trial Info
Start Date :
August 14 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2022
Estimated Enrollment :
325 Patients enrolled
Trial Details
Trial ID
NCT03241771
Start Date
August 14 2017
End Date
August 31 2022
Last Update
August 24 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Denver Health
Denver, Colorado, United States, 80204